Literature DB >> 29370470

Association of betaine with blood pressure in dialysis patients.

Lulu Wang1, Mingming Zhao2,3, Wenjin Liu1, Xiurong Li4, Hong Chu5, Youwei Bai6, Zhuxing Sun7, Chaoqing Gao8, Lemin Zheng2,3, Junwei Yang1.   

Abstract

Mechanisms underlying elevated blood pressure in dialysis patients are complex as a variety of non-traditional factors are involved. We sought to explore the association of circulating betaine, a compound widely distributed in food, with blood pressure in dialysis patients. We used baseline data of an ongoing cohort study involving patients on hemodialysis. Plasma betaine was measured by high performance liquid chromatography in 327 subjects. Blood pressure level was determined by intradialytic ambulatory blood pressure monitoring. The mean age of the patients was 52.6 ± 11.9 years, and 58.4% were male. Average interdialytic ambulatory systolic and diastolic blood pressure were 138.4 ± 22.7 mm Hg and 84.4 ± 12.5 mm Hg, respectively. Mean plasma betaine level was 37.6 μmol/L. Multiple linear regression analysis revealed significant associations of betaine with both systolic blood pressure (β = -3.66, P = .003) and diastolic blood pressure (β = -2.00, P = .004). The associations persisted even after extensive adjustment for cardiovascular covariates. Subgroup analysis revealed that the association between betaine and blood pressure was mainly limited to female patients. Our data suggest that alteration of circulating betaine possibly contributes to blood pressure regulation in these patients. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  betaine; blood pressure; cardiovascular disease; dialysis; hypertension

Mesh:

Substances:

Year:  2018        PMID: 29370470      PMCID: PMC8030815          DOI: 10.1111/jch.13190

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia.

Authors:  W J Dellow; S T Chambers; M Lever; H Lunt; R A Robson
Journal:  Diabetes Res Clin Pract       Date:  1999-02       Impact factor: 5.602

2.  Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.

Authors:  David O McGregor; Warwick J Dellow; Richard A Robson; Michael Lever; Peter M George; Stephen T Chambers
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.

Authors:  A G Bostom; D Shemin; M R Nadeau; V Shih; S P Stabler; R H Allen; J Selhub
Journal:  Atherosclerosis       Date:  1995-02       Impact factor: 5.162

4.  Recombinant human liver betaine-homocysteine S-methyltransferase: identification of three cysteine residues critical for zinc binding.

Authors:  A P Breksa; T A Garrow
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

5.  Blood pressure and mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

Review 6.  Betaine in human nutrition.

Authors:  Stuart A S Craig
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

7.  Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

Authors:  Rajiv Agarwal; Allen R Nissenson; Daniel Batlle; Daniel W Coyne; J Richard Trout; David G Warnock
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

8.  Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women.

Authors:  Svetlana V Konstantinova; Grethe S Tell; Stein Emil Vollset; Ottar Nygård; Øyvind Bleie; Per Magne Ueland
Journal:  J Nutr       Date:  2008-05       Impact factor: 4.798

9.  Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic.

Authors:  Michael Lever; Wendy Atkinson; Peter M George; Stephen T Chambers
Journal:  Clin Biochem       Date:  2007-07-17       Impact factor: 3.281

10.  Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects.

Authors:  Ursula Schwab; Anneli Törrönen; Leena Toppinen; Georg Alfthan; Markku Saarinen; Antti Aro; Matti Uusitupa
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

View more
  1 in total

1.  Association of betaine with blood pressure in dialysis patients.

Authors:  Lulu Wang; Mingming Zhao; Wenjin Liu; Xiurong Li; Hong Chu; Youwei Bai; Zhuxing Sun; Chaoqing Gao; Lemin Zheng; Junwei Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.